TR201722304A2 - Pharmaceutical capsule compositions of oseltamivir phosphate - Google Patents

Pharmaceutical capsule compositions of oseltamivir phosphate Download PDF

Info

Publication number
TR201722304A2
TR201722304A2 TR2017/22304A TR201722304A TR201722304A2 TR 201722304 A2 TR201722304 A2 TR 201722304A2 TR 2017/22304 A TR2017/22304 A TR 2017/22304A TR 201722304 A TR201722304 A TR 201722304A TR 201722304 A2 TR201722304 A2 TR 201722304A2
Authority
TR
Turkey
Prior art keywords
oseltamivir phosphate
pharmaceutical capsule
capsule compositions
pharmaceutical
oseltamivir
Prior art date
Application number
TR2017/22304A
Other languages
Turkish (tr)
Inventor
Türkyilmaz Ali̇
Pehli̇van Akalin Nur
Çfçi̇ Burçe
Original Assignee
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2017/22304A priority Critical patent/TR201722304A2/en
Publication of TR201722304A2 publication Critical patent/TR201722304A2/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to a pharmaceutical capsule composition comprising oseltamivir phosphate as active substance, wherein a d (0.9) particle size of oseltamivir phosphate is not less than 200 ?m.
TR2017/22304A 2017-12-27 2017-12-27 Pharmaceutical capsule compositions of oseltamivir phosphate TR201722304A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2017/22304A TR201722304A2 (en) 2017-12-27 2017-12-27 Pharmaceutical capsule compositions of oseltamivir phosphate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2017/22304A TR201722304A2 (en) 2017-12-27 2017-12-27 Pharmaceutical capsule compositions of oseltamivir phosphate

Publications (1)

Publication Number Publication Date
TR201722304A2 true TR201722304A2 (en) 2019-07-22

Family

ID=67901202

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2017/22304A TR201722304A2 (en) 2017-12-27 2017-12-27 Pharmaceutical capsule compositions of oseltamivir phosphate

Country Status (1)

Country Link
TR (1) TR201722304A2 (en)

Similar Documents

Publication Publication Date Title
PH12020550703A1 (en) Sulfonamide compounds and use thereof
MY196909A (en) Boronic acid derivatives and therapeutic uses thereof
PH12020550341A1 (en) Niraparib formulations
MX2023011657A (en) Compositions comprising curons and uses thereof.
MX370450B (en) Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator.
EA201990831A1 (en) MIXING SYSTEM FOR COSMETIC PRODUCT AND COSMETIC CAPSULE
MX378732B (en) Solid forms
PH12019500731A1 (en) Novel monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as prmt5 inhibitors
PH12018500852A1 (en) Novel cryptophycin compounds and conjugates, their preparation and their therapeutic use
EP4327880A3 (en) Solid state form of ribociclib succinate
UA109661C2 (en) PHARMACEUTICAL COMPOSITION OF TRAMADOL AND COXYBY CO-CRYSTALS
MX2022008034A (en) Antioxidant extracts and compositions.
MX2016001422A (en) Pharmaceutical compositions of fingolimod.
PH12019502635A1 (en) Crystalline form of n-butyldeoxygalactonojirimycin
MX392143B (en) Cosmetic skincare compositions
MX2016008527A (en) Solid preparation comprising tofogliflozin and method for producing same.
WO2019103875A3 (en) Methods of using and compositions containing dulaglutide
MX2019010228A (en) Composition for controlled release of physiologically active substances and process for its preparation.
PH12021551396A1 (en) Active ester derivatives of testosterone, compositions and uses thereof
MX2022013576A (en) Composition for controlled release of physiologically active substances and process for its preparation.
MY192720A (en) Compound having effect of inhibiting platelet aggregation and salt thereof, and composition for preventing or treating thrombotic diseases, containing same
MA39877A (en) Solid forms of a pharmaceutically active compound
NZ760781A (en) Process for the preparation of standardized composition of arjunoglucoside from the bark of terminalia arjuna
PH12019500024A1 (en) Pharmaceutical compositions
MX2020011170A (en) 1-imidazothiadiazolo-2h-pyrrol-5-one derivatives.